Profound Medical (PROF) Net Cash Flow (2018 - 2026)
Profound Medical has reported Net Cash Flow over the past 8 years, most recently at $34.9 million for Q4 2025.
- For Q4 2025, Net Cash Flow rose 17.95% year-over-year to $34.9 million; the TTM value through Dec 2025 reached $2.9 million, down 90.62%, while the annual FY2025 figure was $2.7 million, 91.39% down from the prior year.
- Net Cash Flow for Q4 2025 was $34.9 million at Profound Medical, up from -$9.6 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $34.9 million in Q4 2025 and troughed at -$39.9 million in Q4 2021.
- A 5-year average of -$465250.0 and a median of -$6.0 million in 2021 define the central range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 508.03% in 2022 and fell as far as 208.82% in 2022.
- Year by year, Net Cash Flow stood at -$39.9 million in 2021, then grew by 4.78% to -$38.0 million in 2022, then skyrocketed by 80.18% to -$7.5 million in 2023, then soared by 492.61% to $29.6 million in 2024, then grew by 17.95% to $34.9 million in 2025.
- Business Quant data shows Net Cash Flow for PROF at $34.9 million in Q4 2025, -$9.6 million in Q3 2025, and -$13.7 million in Q2 2025.